XXI Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$370K Sell
2,598
-384
-13% -$58.2K 0.15% 156
2026
Q2
$467K Buy
2,982
+514
+21% +$77.1K 0.21% 115
2026
Q1
$377K Buy
+2,468
New +$378K 0.21% 126

Other funds holding NVS

XXI Wealth's NVS Position: Q3 2026 in Review

XXI Wealth reduced its Novartis (NVS) stake by 13% in Q3 2026, selling an estimated $58.2K and leaving 2,598 shares worth $370K. The position accounts for 0.15% of the portfolio, ranked #156.

XXI Wealth first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $467K in Q2 2026. 1,543 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • XXI Wealth held 2,598 shares of Novartis worth $370K as of Q3 2026.
  • XXI Wealth sold 384 Novartis shares in Q3 2026, an estimated $58.2K.
  • Novartis made up 0.15% of XXI Wealth's portfolio in Q3 2026, its #156 holding.
  • XXI Wealth first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
  • XXI Wealth's Novartis position peaked at $467K in Q2 2026.
  • 1,543 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.